Loading...
Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial
IMPORTANCE: New antibacterials are needed to treat community-acquired bacterial pneumonia (CABP) because of growing antibacterial resistance and safety concerns with standard care. OBJECTIVE: To evaluate the efficacy and adverse events of a 5-day oral lefamulin regimen in patients with CABP. DESIGN,...
Saved in:
| Published in: | JAMA |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Medical Association
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6865224/ https://ncbi.nlm.nih.gov/pubmed/31560372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.15468 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|